| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.0025 | 1 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0024 | 1 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | 0.0077 | 1 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | -0.0035 | 1 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | -0.0027 | 1 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |